In Vitro Transcribed mRNA · Gene Editing
Ultra-clean mRNA
Low double-stranded RNA content, Cap1 capping, and stabilized poly(A) architecture — from reporters to Cas9.
Spec Sheet
Compare at a glance
Pick the payload that matches your workflow — from reporter validation to functional gene editing.
| PRODUCT | USE CASE | KEY DIFFERENTIATOR | MODIFICATION | SIZES |
|---|---|---|---|---|
|
Neat™ Luciferase-mRNA
|
Luminescent expression assay | Quantifiable readout via standard luminometer — no imaging needed | 5' Cap1 · N1-Me-Pseudouridine |
|
|
Neat™ eGFP-mRNA
|
Live-cell fluorescent imaging | Real-time visualization in living cells — no substrate or fixation | 5' Cap1 · N1-Me-Pseudouridine |
|
|
Neat™ SpCas9 mRNA
|
CRISPR gene / cell therapy editing | >10× fewer off-target edits than wild-type SpCas9 | Cap1 |
|
Shared mRNA Architect
See the difference, assay by assay
Head-to-head against standard IVT mRNA, run under matched conditions.
Where They Fit
Built for the transfection bench
All three transcripts are delivered the same way — via your standard transfection reagent — and support the same core workflow, from optimization to functional editing.
Transfection optimization
Expression & imaging assays
CRISPR gene & cell therapy
Ready to bring these into your workflow?
Request volume pricing, a certificate of analysis, or a technical consult — our team responds within one business day.
